Clinical trial

Study on Tolerability of Repeat i.c.v. Administration of sNN0031 Infusion Solution in Patients With PD

NCT02408562

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

OTHER · Unmapped registry intervention i.c.v. infusion of sNN0031 by an Implanted infusion system Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention i.c.v. infusion of aCSF by an Implanted infusion system Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study on Tolerability of Repeat i.c.v. Administration of sNN0031 Infusion Solution in Patients With PD

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1, PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2015-01-01

PhasePHASE1 / PHASE2

Conditions

Parkinson's Diseaseverified · MONDO: Parkinson disease

Interventions

i.c.v. infusion of sNN0031 by an Implanted infusion systemOTHER

i.c.v. infusion of aCSF by an Implanted infusion systemOTHER

Sponsors & collaborators

Newron Sweden ABlead sponsor

European Unioncollaborator

Mapped research locations

LondonUnited Kingdom1 StockholmSweden1 LundSweden1 OxfordUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02408562 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.